102 related articles for article (PubMed ID: 12243114)
1. Method of risk assessment affects acceptance rate of amniocentesis.
de la Vega A; Verdiales M; Leavitt G
P R Health Sci J; 2002 Sep; 21(3):233-5. PubMed ID: 12243114
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic results of amniocentesis materials: incidence of abnormal karyotypes in the Turkish collaborative study.
Karaoguz MY; Bal F; Yakut T; Ercelen NO; Ergun MA; Gokcen AB; Biri AA; Kimya Y; Urman B; Gultomruk M; Egeli U; Menevse S
Genet Couns; 2006; 17(2):219-30. PubMed ID: 16970041
[TBL] [Abstract][Full Text] [Related]
3. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
Sharda S; Phadke SR
J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
[TBL] [Abstract][Full Text] [Related]
4. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women.
Danisman N; Kahyaoglu S; Celen S; Kahyaoglu I; Candemir Z; Yesilyurt A; Cakar ES
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):242-5. PubMed ID: 23025698
[TBL] [Abstract][Full Text] [Related]
6. [How to improve the screening and diagnosis of fetal aneuploidy?].
Ville Y
Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
[TBL] [Abstract][Full Text] [Related]
7. The influence of IVF, multiple gestation and miscarriage on the acceptance of genetic amniocentesis.
Elimian A; Demsky M; Figueroa R; Ogburn P; Spitzer AR; Gerald Quirk J
Prenat Diagn; 2003 Jun; 23(6):501-3. PubMed ID: 12813766
[TBL] [Abstract][Full Text] [Related]
8. [Amniocentesis practice assessment of the south-west Francilian network during 2003].
Laperrelle J; Senat MV; Picone O; Fernandez H; Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):135-42. PubMed ID: 18036746
[TBL] [Abstract][Full Text] [Related]
9. Impact of genetic counseling on primary and preventive care in obstetrics and gynecology.
Cohn GM; Miller RC; Gould M; Macri CJ; Gimovsky ML
J Reprod Med; 1999 Jan; 44(1):7-10. PubMed ID: 9987732
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester genetic amniocentesis: 5-year experience.
Turhan NO; Eren U; Seçkin NC
Arch Gynecol Obstet; 2005 Jan; 271(1):19-21. PubMed ID: 15290165
[TBL] [Abstract][Full Text] [Related]
11. Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: need for improvement in informed consent process.
Marini T; Sullivan J; Naeem R
Am J Med Genet; 2002 May; 109(3):171-5. PubMed ID: 11977174
[TBL] [Abstract][Full Text] [Related]
12. Reporting partial screening results: is it confusing and unsatisfactory?
Mulvey S; Wallace EM
Prenat Diagn; 2002 Jul; 22(7):633; author reply 633-4. PubMed ID: 12124702
[No Abstract] [Full Text] [Related]
13. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?
Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA
Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427
[TBL] [Abstract][Full Text] [Related]
14. [Controversy: systemic amniocentesis for women 38 years and more? Is it not premature to no longer accept performing amniocentesis on a patient age 38 years or more?].
Sagot P
Gynecol Obstet Fertil; 2000 Oct; 28(10):769-71. PubMed ID: 11270348
[No Abstract] [Full Text] [Related]
15. Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers.
Muller F; Thibaud D; Poloce F; Gelineau MC; Bernard M; Brochet C; Millet C; Réal JY; Dommergues M
Prenat Diagn; 2002 Nov; 22(11):1036-9. PubMed ID: 12424771
[TBL] [Abstract][Full Text] [Related]
16. The importance of genetic counseling before amniocentesis.
Cohn GM; Gould M; Miller RC; Habecker-Green J; Macri CJ; Gimovsky ML
J Perinatol; 1996; 16(5):352-7; quiz 358-9. PubMed ID: 8915933
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal diagnosis of chromosomic defects in Costa Rica].
Castro Volio I
Rev Biol Trop; 2004 Sep; 52(3):545-9. PubMed ID: 17361548
[TBL] [Abstract][Full Text] [Related]
18. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Saller DN; Canick JA
Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
[TBL] [Abstract][Full Text] [Related]
19. First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation.
Philipson EH; Callahan M; Jelovsek JE
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):218-22. PubMed ID: 18669714
[TBL] [Abstract][Full Text] [Related]
20. The role of genetic counseling on decisions of pregnant women aged 35 years or over regarding amniocentesis in Turkey.
Ilgin-Ruhi H; Yürür-Kutlay N; Tükün A; Bökesoy I
Eur J Med Genet; 2005; 48(1):13-9. PubMed ID: 15953401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
